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ABSTRACT Five monoclonal antibodies against sperm whale myoglobin have been used to investigate the physical state
of the antigen adsorbed onto a polydimethylsiloxane surface. The binding of each antibody is sensitive to the antigen's
conformation in solution while the locations of the antigenic sites on the myoglobin molecule for three of the antibodies
have been determined (Berzofsky, J. A., G. K. Buckenmeyer, G. Hicks, F. R. N. Gurd, R. J. Feldmann, and J. Minna.
1982. J. Biol. Chem. 257:3189-3198). The binding of the fluorescein isothiocyanate-labeled IgG and Fab antibodies to
previously adsorbed myoglobin has been observed using total internal reflection fluorescence. Three of the antibodies
bind specifically to surface-adsorbed myoglobin with affinities at least 50% relative to myoglobin in solution whereas
two of the antibodies show affinities for the surface-adsorbed myoglobin diminished by at least two orders of magnitude
relative to myoglobin in solution. The specific loss of certain antigenic determinants on the adsorbed myoglobin, coupled
with the retention of others, indicates a nonrandom adsorption of the myoglobin molecules.
INTRODUCTION
Proteins and other macromolecules generally adsorb onto
solid/liquid interfaces. The conformation and orientation
of adsorbed proteins are thought to affect a number of
processes. For example, the physical state of adsorbed
proteins is believed to influence cell/substrate interactions
(1-3). It is recognized that the thrombogenic response of
blood towards artificial surfaces is influenced by proteins
in the adsorbed layer (4, 5). Protein adsorption accompa-
nied by alterations in molecular conformation or by spatial
ordering on the surface may also have important implica-
tions for the use of antibody-antigen assays involving the
adsorption of protein antigen onto a solid surface (6). In
this regard, it is interesting to note documented examples
of hybridoma supernatants that exhibit false positives in
solid-phase immunoadsorbent screening assays. That is, a
monoclonal antibody is found that reacts strongly with the
antigen adsorbed to microtiter plates but is subsequently
found not to react well with the antigen in solution (7-10).
Such antibodies sometimes bind more strongly to the
antigen in solution after the antigen has been denatured by
heat or by the reduction of disulfide bonds (9).
Very little direct information is available concerning the
relationship between protein adsorption and conformation.
Probably the most compelling evidence that conforma-
tional changes can occur subsequent to the adsorption of
proteins to solid surfaces is the observation, in some cases,
of alterations in the circular dichroism spectra of desorbed
protein as compared with native protein (1 1, 12). Conclu-
sions about the effects of surface-adsorption on protein
conformation have also been inferred from results obtained
using ellipsometry and infrared spectroscopy (13). micro-
calorimetry and potentiometric titrations (14), and total
internal reflection fluorescence (15). Virtually no informa-
tion is available at the molecular level concerning the
conformation and orientation of an adsorbed protein.
With the goal of defining the physical state of a surface-
adsorbed protein in terms of its conformation and orienta-
tion, we have undertaken a study of the adsorption of
sperm whale myoglobin (Mb) to a polydimethylsiloxane
(PDMS; filler-free silicone rubber) surface. A preliminary
characterization of the adsorption behavior of Mb on
PDMS has been presented (16). The Mb/PDMS system
used in this study serves as a model system of protein
adsorption onto solid surfaces. PDMS forms a relatively
hydrophobic surface and thus the noncovalent interactions
involved in the adsorption process and the qualitative
aspects of the results obtained herein are expected to apply
to other proteins adsorbing onto hydrophobic surfaces in a
general sense.
The use of Mb offers several advantages. Mb is a
thoroughly studied and characterized protein with respect
to its solution properties and structure (17, 18). In addi-
tion, monoclonal antibodies that have been characterized
with respect to their antigenic sites on the Mb molecule are
available (19, 20). The observation that none of these
antibodies recognize denatured fragments of Mb suggest
that the binding of each antibody is sensitive to the
antigen's conformation. Furthermore, the positions on the
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protein antigen of amino acid residues essential for the
binding of three of the antibodies have been determined.
Strong arguments have been presented that these essential
amino acids are contained within the antigenic sites for the
three antibodies (20). Two of these antibodies recognize
groups of residues which are far apart in the primary
sequence but close together in the folded, tertiary structure
of the antigen, demonstrating the topographic, as opposed
to sequential, nature of the antigenic sites. Here we present
an investigation of the binding characteristics of five of
these monoclonal antibodies with Mb adsorbed onto a
PDMS surface.
MATERIALS AND METHODS
Myoglobin
Sperm whale Mb (Biozyme, Batch 2, Accurate Chemical and Scientific,
Hicksville, NY) was repurified by the method of Hapner et al. (21) as
described previously (22). The major component IV, using the notation of
Garner et al. (23), was used throughout. Mb concentration was deter-
mined from the visible absorption at 540 nm using an extinction coeffi-
cient of 10.4 mM-' cm-' for the ferric cyanide derivative (24). A
molecular weight of 17,800 was used in any calculations.
Antibodies
The preparation, subclass, affinity, and binding site characterizations of
the monoclonal anti-Mb IgG antibodies have been described previously
(19, 20). Clones 1, 3.4, 4, and 5 are 'K, whereas clone 2 is UK. All were
made by fusing spleens of hyperimmunized A.SW mice with NS1, a
nonsecreting derivative of the P3 x 63 plasmacytoma cell line. The
antibodies were affinity purified from culture supernatant (clone 1) or
ascites (all others) by affinity chromatography on Mb-Sepharose, elution
with 0.1 M glycine * HCI (pH 3), and immediate neutralization with Tris,
pH 8.
For studies incorporating non-Mb-specific antibodies, purified mouse
MOPC 21 myeloma protein (lot 03604; Litton Bionetics, Kensington,
MD) was used.
Fab Fragments
Fab fragments of each of the IgG antibodies were prepared by digestion
with papain immobilized on an agarose gel (Pierce Chemical Co.,
Rockford, IL). Typically, 0.5 ml of the papain-agarose (- 130 ,ug papain)
was added to 5 mg antibody dissolved in 1 ml of 20 mM sodium
phosphate, 50 mM cysteine * HCI, 10 mM sodium EDTA, pH 6.2. The
mixture was incubated for 5 h at 370C with gentle rocking. The
immobilized papain was separated by centrifugation (8,800 g for 10 min).
The supernatant was desalted by size exclusion chromatography (1 x 10
cm column) in 10 mM sodium phosphate, pH 8.50. The protein fraction
was then applied to a 5-ml column of protein A-Sepharose CL-4B
(Pharmacia, Uppsala, Sweden) equilibrated in 10mM sodium phosphate,
pH 8.50, to remove Fc fragments and undigested IgG. Although protein
A binds mouse IgG, (clones 1, 3.4, 4, and 5) only very weakly at neutral
pH, IgG, and IgG2, (clone 2) antibodies are bound quantitatively and
with high affinity above pH 8.0 (25). The eluted Fab fragments were
collected and stored for further use. The protein A column was regener-
ated with 0.1 M glycine * HCI, pH 2.80.
The IgG digestion and Fab purification steps were followed by
size-exclusion high-performance liquid chromatography (HPLC) (Bio-
Sil TSK-250 column, 7.5 x 300 mm; Bio-Rad Laboratories, Richmond,
CA) in 20 mM sodium phosphate, 0.1 m Na2SO4, pH 6.80. Undigested
IgG was found to have an elution volume of 8.60 ml at the conditions used.
As the papain digestion proceeded, the IgG peak, monitored by the
absorbance at 280 nm, decreased in intensity while a new peak with an
elution volume of 10.2 ml appeared. This was presumably Fab and Fc
fragments coeluting due to their similar molecular weights. After 5 h of
digestion, the area under the IgG peak was <5% of the Fab-Fc peak.
After the protein A-affinity chromatography, any IgG left in the sample
was too dilute to be detected by its absorbance at 280 nm.
[3H] Fluorescein Isothiocyanate Antibodies
Clone 4 IgG and each of the Fab samples, prepared as described above,
were labeled with fluorescein isothiocyanate (FITC) by covalent attach-
ment to primary amine groups (mainly lysine residues) of the proteins
(26). Antibody was incubated with a 100 times molar excess of FITC in
0.1 M sodium borate, pH 9.5, for 1 h. The unreacted FITC was removed
by size-exclusion chromatography (1 x 20 cm column) in 0.1 M sodium
borate, pH 9.0. The labeled protein and unreacted FITC were observed as
well-defined, yellow bands separated by more than half the column length
when the protein fraction eluted from the column.
The FITC-antibody was immediately tritiated by a reductive methyla-
tion technique (27). At 0°C, the FITC-antibody was mixed with a 20
times molar excess of formaldehyde and a five times molar excess of
sodium [3H]borohydride (lot 2273-097, 62.0 Ci/mmol; New England
Nuclear, Boston, MA). After 1 min, a 500 times molar excess of lysine
was added to quench the reaction. The labeled protein was separated from
low molecular weight components of the mixture by size-exclusion
chromatography (1 x 20 cm column) in 10 mM sodium phosphate, 150
mM NaCl, 3 mM NaN3, pH 7.40. Each of the labeled samples behaved
identically to unlabeled samples of the same protein upon size-exclusion
HPLC as described above. The labeled samples were stored at 40C and
used within 1 wk.
Protein concentrations and fluorescein labeling densities were deter-
mined spectrophotometrically. Extinction coefficients for IgG
((276 nm= 200 mM-'cm-1) and for antibody-bound fluorescein
((276= 22 mM-'cm-'and E493nm = 60 mM-'cm-' at pH 7.4) have been
determined previously (26). An extinction coefficient of 78 mM -'cm-' at
276 nm was used for Fab concentration determination (28). Fluorescein
labeling densities were typically 1 to 2 (moles fluorescein per mole
antibody). The specific activities of the labeled antibodies, determined by
liquid scintillation counting, ranged from 0.5 to 1 Ci/mmol. Molecular
weights for IgG and Fab of 150,000 and 50,000, respectively, were used in
any calculations.
Radioimmunoassay
The immunological activities of the labeled samples of clone 4 IgG and
clones 1, 2, 3.4, 4, and 5 Fab were determined by solution radioimmunoas-
says. Mb was labeled with N-succinimidyl-[2,3-3H]propionate (batch 39,
105 Ci/mmol; Amersham Corp., Arlington Heights, IL) as described
previously (19).
The radiobinding assay for the labeled clone 4 IgG using polyethylene
glycol (6,000-7,000 mol w; final concentration, 10% by weight) to
precipitate the IgG plus bound antigen, was performed as described
previously (22). A Scatchard analysis (data not shown) indicated that the
labeled clone 4 IgG affinity for Mb was 5 x 108 M-' and essentially 100%
of the protein in the sample was active. The measured affinity is well
within experimental error of the affinity for clone 4 IgG (7.1 x 108 M')
determined previously (19).
Because polyethylene glycol does not precipitate Fab fragments effec-
tively, a second-antibody precipitation scheme was used. Fab, carrier
antibody (mouse IgG, lot 0071; Miles Scientific Div., Miles Laboratories
Inc., Naperville, IL) and [3H]Mb were mixed in 10 mM sodium
phosphate, 150 mM NaCl, 3 mM NaN3, pH 7.40. After incubation for 2
h at room temperature, second antibody was added (affinity-purified goat
anti-mouse IgG, F(ab')2, lot 4922; Pel Freez Biologicals, Rogers, AK).
The final Fab, carrier, and second antibody concentrations were 0.20,
0.67 and 7.2 uM, respectively, while the Mb concentration was varied.
The final volume was 0.10 ml. The precipitation reaction was allowed to
proceed for 48 h at 40C. After centrifugation at 8,800 g for 30 min, the
BIOPHYSICAL JOURNAL VOLUME 53 1988534
supernatant was removed and counted. Controls with Mb-specific Fab
absent precipitated less than 5% of the radioactive Mb, whereas >95% of
the radioactive Mb could be precipitated by the specific samples. From
Scatchard analyses of the data (not shown), each labeled Fab sample
exhibited an affinity for Mb within 50% of the affinity determined for the
undigested and unlabeled antibody (19, 20). At least 80% of the protein in
each sample was active. These results were taken to indicate that, for the
purposes of this study, the immunological activity of the Fab fragments
was not significantly perturbed by the digestion and labeling procedures.
Total Internal Reflection Fluorescence
Apparatus and PDMS Films
A total internal reflection fluorescence (TIRF) instrument described
previously (29) was used. Also discussed in this prior publication are the
techniques used to deposit and characterize PDMS films on glass slides.
Adsorbed protein surface concentrations were determined and related to
the TIRF signals as described elsewhere (29) with the modifications of
Darst et al. (16). For both [3H]FITC-IgG and [3H]FITC-Fab, the
fluorescence signals were found to be proportional to the surface concen-
tration over the range of surface concentrations encountered.
TIRF Experimental Protocol
The same general experimental methods described previously (29) were
used for the TIRF experiments. Prior to an experiment, the protein
solution reservoirs were incubated for several hours with a Mb or antibody
solution of equal concentration to that used in the experiment to prevent
loss of protein by adsorption onto the glass walls of the reservoir. Unless
otherwise specified, the following protocol was used for the TIRF
experiments. Mb was adsorbed from a flowing solution (wall shear rate 94
s_') onto a PDMS film for 10 h. The Mb solution concentration was 8.5
Ag/ml in 10 mM sodium phosphate, 150 mM NaCl, 3 mM NaN3, pH
7.40. The temperature was controlled at 37 ± 0.50C. Under these
conditions, the Mb surface concentration was found to be 94 ± 6 ng/cm2
(5.3 ± 0.3 pmol/cm2). After 10 h, the flowing Mb solution was replaced
with a solution of [3H] FITC-antibody. The adsorption of the [3H]FITC-
antibody to the previously adsorbed Mb was then monitored continuously
using TIRF.
Nonspecific Adsorption of Antibody
To determine the specific interactions of anti-Mb antibodies with
adsorbed Mb, the extent of nonspecific antibody adsorption must be
known. The adsorption of FITC-bovine--y-globulins to adsorbed Mb have
been investigated previously (16). For the purposes of this study, nonspe-
cific adsorption of antibody was determined by exposing layers of
adsorbed Mb to various concentrations of [3H]FITC-IgG and [3H]FITC-
Fab fragments of the MOPC 21 myeloma protein of P3 x 63. This
molecule originates from the protein-secreting parent of NS1 and, being
also 81K but without specificity for Mb, serves as a good control.
When the PDMS surface was exposed to high solution concentrations
of Mb (30 ,g/ml or higher), a saturating amount of Mb was adsorbed
(-130 ng/cm2). As found previously (16), the nonspecific adsorption of
antibody to the Mb-saturated surface was negligible for up to 20 h. The
amount of nonspecifically adsorbed antibody increased as the surface
concentration of Mb decreased. Nonspecifically adsorbed antibody thus
appears to interact with surface sites distinct from the adsorbed Mb
molecules, probably vacant regions remaining on the surface when the
Mb surface concentration fails to reach saturation.
For the anti-Mb antibody studies reported herein, the PDMS surfaces
were -70% saturated with Mb (94 ng/cm2 vs. 130 ng/cm2 for a saturated
surface). Exposure of such a surface to anti-Mb antibody in solution will
result in nonspecific antibody/PDMS interactions as well as the potential
antibody/adsorbed Mb interactions of interest. The amount of specifi-
cally adsorbed antibody for a given antibody solution concentration was
determined by simply subtracting from the total amount of adsorbed
antibody the amount of nonspecifically adsorbed antibody determined at
the same solution concentration. MOPC 21 IgG adsorption was used to
correct for the specific IgG adsorption results whereas MOPC 21 Fab
adsorption was used to correct for the specific Fab results. At the highest
IgG solution concentration observed (125 nM), after 2 min of antibody
adsorption to previously adsorbed Mb, the total amount of adsorbed clone
4 IgG was 40 ng/cm2, whereas in a separate experiment the amount of
adsorbed MOPC 21 IgG was 4.6 ng/cm2. At lower antibody solution
concentrations, when specific antibody/adsorbed Mb interactions were
observed, the nonspecific antibody adsorption was always less than 10% of
the total antibody adsorption for both IgG and Fab binding. In perform-
ing these minor corrections, the assumption is made that small numbers of
amino acid changes within the binding site regions of each antibody do not
significantly affect the nonspecific adsorption properties and thus the
nonspecific binding does not vary from antibody to antibody. This is
supported by the finding described above that the nonspecific binding
results using MOPC 21 myeloma protein are essentially identical to those
obtained using a heterogeneous bovine--y-globulins sample.
Model Used to Interpret the Antibody
Binding Results
The simple model used to interpret the antibody binding results is shown
schematically in Fig. 1. Nonspecific adsorption of antibody to the PDMS
surface is neglected in this model because only relatively small amounts of
nonspecific antibody binding were observed and this was taken into
account as described above. The model is essentially the same as those
used to describe the equilibrium binding of antibodies or ligands to cell
surface receptors (30) with the conceptual difference that the adsorbed
Mb is probably not able to diffuse freely in the surface plane. Although
the mobility of adsorbed protein in the surface plane could affect the
kinetics of the binding process, assumptions regarding surface mobility
are not required to analyze the equilibrium binding results. The binding of
an antibody is described by the linked equilibria (* indicates surface
bound species):
Ab + Mb*. Ab-l
Abr + Mb*
-Ab2*
[Ab*]
[Ab] [Mb*]
[Ab*l
[Abr] [Mb*]
(1)
(2)
where Ab denotes free antibody in solution, Mb* denotes adsorbed Mb,
and Abr and Ab* denote the mono- and bivalently bound antibody,
respectively. K, and K2 are the univalent and bivalent association
constants, respectively. The quantity measured experimentally is the total
Ab
K
Ab! K2 Ab277- /j:7 Mb'
PDMS SURFACE
FIGURE 1 Schematic representation of the model used to interpret the
antibody binding results. *Denotes a surface-bound species. According to
this scheme Mb is bound in some unknown manner to the PDMS surface.
Antibody in the bulk solution (Ab) is in equilibrium with a univalently-
bound antibody/surface-adsorbed Mb complex (Ab*) with an association
constant K1. For bivalent IgG antibodies, AbM is also in equilibrium with
the bivalently-bound species, Ab*, with an association constant K2.
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bound antibody ([Ab,] + [Abf]). A surface coverage, 0, can be defined
in the following manner:
[AbrI + [Ab ]I0- [M~0(3)
where [Mb*]o denotes the total surface concentration of antibody-bound
and free Mb, a known quantity. 0 can be expressed as
0= K1[Ab] + K,K2[Ab] [Mb*]
1 + K,[Ab] + 2KIK2[Ab] [Mb*]'
or in the form of a Scatchard analysis:
0
[Ab] = K, + KIK2[Mb*]- (K + 2K,K2[Mb*])0. (5)
For univalent Fab fragments, K2 = 0 and the expression reduces to
0
[Ab] = K, - KI@ (6)
RESULTS
Clone 4 IgG and Fab Antibodies Interact
Strongly with Adsorbed Mb
Typical experimental results for the binding of the clone 4
antibody to surface-adsorbed Mb are shown in Fig. 2 (see
figure caption for details). Fab and IgG antibodies behave
qualitatively the same.
To derive conclusions from a Scatchard analysis, it must
be demonstrated that a reversible equilibrium exists
TIME (min)
FIGURE 2 Surface-bound antibody fluorescence signal, in units of
photomultiplier tube current, versus time for clone 4 FITC-IgG. Mb was
allowed to adsorb onto a PDMS surface from a flowing solution for 10 h
under the conditions described in Materials and Methods. At time zero,
the Mb solution was replaced by a 63-nM solution of clone 4 FITC-IgG at
a fluorescent labeling density of 1 mol FITC/mol IgG. The adsorption
time lag is due to the time required for the antibody solution to displace
the Mb solution up to the center of the flow cell and diffuse to the surface
point of observation. Under the conditions of this experiment, the
fluoresence signals from nonspecifically adsorbed and from bulk solution
antibody are negligible. A fluoresence signal of 9 nA corresponds to an
antibody surface concentration of 0.18 pmol/cm2. The Mb surface
concentration is 5.3 ± 0.3 pmol/cm2, resulting in a surface coverage of
0.034.
between the antibody in solution and the Mb-bound spe-
cies. Evidence for this arises from two observations. First,
when the antibody solution concentration is stepped, either
up or down, the new antibody surface concentration is the
same as if the experiment was performed in one step.
Second, the Mb-bound antibody can be desorbed by flush-
ing the flow cell with buffer or other solutions, such as
bovine serum albumin. It should be noted that for high
antibody solution concentrations, these equilibria condi-
tions are observed as long as the Mb surface is exposed to
the antibody solution for short times. If antibody adsorp-
tion is allowed to continue, a very slow increase in the
antibody surface concentration occurs (in excess of nonspe-
cific antibody adsorption) and the surface-antibody
desorbs at an increasingly lower rate. For instance, at an
IgG solution concentration of 63 nM, the initial rapid
adsorption plateaus after -5 min at a surface coverage of
-0.03. The antibody surface concentration continues to
slowly increase, however. After 24 h, the surface coverage
of specifically adsorbed antibody is -0.13 and appears to
have attained steady state. If the antibody adsorption
process is interrupted after 5 h, virtually no antibody
desorption occurs for up to 20 h. This long-term process
may be due to aggregation of the surface-bound antibody
but is not entirely understood and is not addressed further
herein. All of the isotherms presented in this work were
determined using data from the initial plateau of the
antibody binding, the time period of which depends on the
antibody solution concentration.
Isotherms for the binding of the antibodies to previously
adsorbed Mb were determined by measuring the antibody
binding over a range of antibody solution concentrations
(0.5-200 nM). A Scatchard analysis of the isotherms for
the clone 4 IgG and Fab antibodies is shown in Fig. 3.
Under conditions of random adsorption, a maximum
surface packing of -55% (surface area covered/total sur-
face area) is expected (31). Using the Stokes radii of the
IgG and Fab molecules calculated from the diffusion
coefficients (28) as approximate molecular dimensions,
0.08
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e
FIGURE 3 Scatchard analyses for clone 4 IgG (0) and Fab (0) binding
to adsorbed Mb. 0 is the fractional surface coverage as defined in the text
(see Materials and Methods). [Ab] denotes the bulk solution antibody
concentration in nM.
BIOPHYSICAL JOURNAL VOLUME 53 1988
a
a
0
0
536
this surface packing corresponds to maximum surface
coverages (0) due to steric limitations for IgG and Fab of
0.09 and 0.25, respectively. This suggests that the clone 4
IgG and Fab adsorption may be limited by steric exclusion
and explains the difference in maximum surface coverage
observed between IgG and Fab, although additional exper-
iments are required to confirm this point.
With Eq. 6, K, can be calculated from the slope of the
Fab isotherm. The slope of the clone 4 Fab isotherm in Fig.
3 is estimated to be -0.53 nM-, yielding a value for K, of
5.3 x 108 M-'. This compares very favorably with the
value of the clone 4 affinity for Mb in solution, 7.1 x 108
M-' (19). The limiting slope, as 0 0, of the clone 4 IgG
isotherm is estimated to be -2.1 nM -'. By comparison of
Eqs. 5 and 6, the steeper slope of the IgG isotherm
indicates that bivalent binding of the IgG molecules
occurs. Using the value of K, determined above for the
clone 4 Fab, K2 can be calculated to be 2.8 x 10"
cm2/mol.
Based on a comparison of the binding rates of the clone 4
antibodies to the adsorbed Mb with the results of a
convection/diffusion model appropriate for the geometry
of the TIRF apparatus (32), at the wall shear rate used (94
s 1) the binding rates of both the IgG and Fab antibodies
are influenced by diffusion. Thus, the intrinsic kinetics of
the forward reaction cannot be discerned from these data.
The desorption rates, which are found to be kinetically
limited, give further indication that the clone 4 IgG
antibodies exhibit bivalent binding at low surface cover-
ages. An apparent desorption rate constant, kd, for the
clone 4 IgG antibody was calculated assuming the follow-
ing rate expression:
dtd =kd,O. (7)
The dependence of kd on 0 is tabulated in Table I. The
significant increase in kd with 0 indicates that for small 0,
the IgG binds bivalently to the adsorbed Mb. As 0
increases, competition among the antibodies for a limited
number of Mb molecules causes an increase in [Ab I]/
[Ab* ]. This results in an increased apparent kd. This
phenomenon should also result in an upward concave
Scatchard plot, which is compatible with the clone 4 IgG
isotherm shown in Fig. 3. However, it would be inappro-
priate to compare the clone 4 IgG isotherm with Eq. 5,
TABLE I
DEPENDENCE OF THE DESORPTION RATE CONSTANT,
kd, ON 0 FOR CLONE 4 IgG BOUND TO
SURFACE-ADSORBED Mb
0 kd(s-' x 104)
0.020 2.1
0.034 2.6
0.045 4.3
owing to the possibility of significant steric limitations
discussed previously.
Due to the complex binding behavior and the increased
severity of the steric limitations for the IgG antibody,
investigations of the binding of clones 1, 2, 3.4, and 5 to the
adsorbed Mb were conducted using Fab fragments only.
Fab Fragments of Clones 1 and 2 Also
Interact Strongly with Adsorbed Mb
The binding behavior of the clone 1 and 2 Fab antibodies to
the adsorbed Mb was qualitatively similar to the behavior
of the clone 4 Fab. The binding kinetics for both antibodies
are diffusion-limited. Isotherms for these antibodies, in the
form of a Scatchard plot, are shown in Fig. 4. From the
estimated slopes of the isotherms, values for K, of 9.5 x 108
M-1 for clone 1 and 1.3 x 109 M' for clone 2 are
determined. These affinity constants are within 50% of
those for Mb in solution, 1.9 x 109 M` for clone 1 and
2.2 x 109 M-'for clone 2.
Fab Fragments of Clones 3.4 and 5 Show
Sharply Diminished Affinities for
Adsorbed Mb
The affinities of the clone 3.4 and clone 5 Fab fragments
for adsorbed Mb are several orders of magnitude less than
their affinities for Mb in solution.
The clone 3.4 Fab fragments do not bind significantly to
the adsorbed Mb. Under the conditions of these experi-
ments, antibodies binding to the adsorbed Mb with an
affinity of -106 M` or less cannot be detected above
background, nonspecific binding. Thus, the K, for the clone
3.4 Fab fragments is 106 M` or less. This is compared to
an affinity for Mb in solution of 2 x 108 M-l (20).
The clone 5 Fab fragments interact weakly with the
adsorbed Mb. The affinity is estimated to be 10-7 M-',
compared to an affinity of 1.6 x 109 M-' for Mb in
solution. In addition to the solution radioimmunoassay
performed to determine the immunological activity of the
clone 3.4 and 5 Fab fragments, another control was
0.03 0.06 0.09 0.12
FIGURE 4 Scatchard analyses for clone 1 Fab (0) and clone 2 Fab (0)
binding to adsorbed Mb. 0 is defined in the text. [Ab] denotes the bulk
solution antibody concentration in nM.
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performed for the clone 5 Fab. It is known that the clone 4
and clone 5 antibodies can bind to the Mb molecule
simultaneously in solution (33). Experiments were con-
ducted in which clone 4 IgG was initially adsorbed to the
PDMS surface and then exposed to Mb. Clone 5 Fab binds
rapidly to the Mb-presenting surface. The maximum Fab
surface concentration was 1.6 pmol/cm2, close to the steric
limit calculated previously. When the adsorbed clone 4
IgG is exposed to bovine serum albumin rather than Mb,
the subsequent adsorption of clone 5 Fab is negligible.
These results indicate that the clone 5 Fab sample used in
this study is active under the conditions of these experi-
ments and that the diminished binding to adsorbed Mb is
due to an effect of the adsorption process on the Mb itself.
DISCUSSION
Table II summarizes the relevant properties of the antibod-
ies investigated in this study, including their affinities for
Mb in solution and for Mb adsorbed onto the PDMS
surface. The amino acid residues essential for the binding
of the clone 1, 3.4, and 5 antibodies are listed. Although the
positions of amino acid residues within the antigenic sites
of the clone 2 and 4 antibodies have not been determined, it
is known that these antibodies can bind simultaneously
with the clone 5 antibody to Mb in solution (33). Thus, the
binding sites for the clone 2 and 4 antibodies must be
distant from the clone 5 antibody site.
The main result of this study is that adsorption of the
protein antigen Mb onto a PDMS surface results in the
specific loss of some antigenic determinants (clones 3.4 and
5) whereas others are unaffected (clones 1, 2, and 4). The
loss of antigenic determinants can be due to two effects.
First, conformational changes of the adsorbed Mb could
disrupt the antigenic sites. Second, the orientation of the
adsorbed Mb on the surface could render the antigenic
sites sterically inaccessible to antibody.
Significant conformational changes to the antigenic site
for any of the antibodies investigated in this study would
result in a decreased affinity (20). Conformational
changes of the Mb molecule due to the adsorption process,
TABLE II
SUMMARY OF THE Mb BINDING PROPERTIES OF THE
MONOCLONAL ANTI-Mb ANTIBODIES
Affinity for Mb
Clone Essential (M-' x 109)Mb amino acid residues*
Solutiont Surface
1 Glu 83,Ala 144, Lys 145 1.9 0.95
2 Unknown 2.2 1.3
3.4 Glu 4, His 12, Lys 79 0.2 --lo-
4 Unknown 0.71 0.53
5 Lys 140 1.6 10-2
*From reference 20. tFrom reference 19, except for clone 3.4, which is
from reference 20.
if occurring at all, are confined to local regions of the
adsorbed Mb. Although conformational changes to the
antigenic sites of the clone 3.4 and 5 antibodies may cause
the diminished binding of these antibodies, the binding
affinities of the clone 1, 2, and 4 antibodies are essentially
unaffected by the adsorption process, indicating the topog-
raphy of the antigenic sites for these antibodies is not
significantly altered by adsorption-related phenomena. In
this regard it is of interest that the binding of the clone 1
and 4 antibodies, but not clone 5, perturb the spin-state
equilibrium of the Mb heme slightly toward low spin
relative to high spin at pH 8.7, near the dissociation
constant (pK) (34). This effect is presumed to be due to the
stabilization by antibody binding of a particular conforma-
tion of the protein. Although all of these antibodies bind to
the "native" Mb conformation, in solution it is likely that
the "native" state is an equilibrium mixture of several
substates, all approximating the crystal structure but
differing slightly from one another. Thus, one interpreta-
tion compatible with these results and those herein is that
the clone 1 and 4 antibodies bind preferentially to a
different conformational state from that preferred by the
clone 5 antibody. Adsorption of Mb on the PDMS surface
may stabilize the former state and disfavor the latter. A
testable prediction of this hypothesis is that the ratio of
low- to high-spin heme would be slightly greater, and the
pK for dissociation of a proton from water bound at the
heme would be slightly lower, on the PDMS surface than
in solution.
The absence of more detailed knowledge concerning the
locations on the Mb molecule of the clone 2 and 4 antibody
binding sites makes it difficult to draw conclusions about
possible orientation of the adsorbed Mb molecules.
Regardless of whether the diminished affinities of the
clone 3.4 and 5 antibodies are due to conformational or
steric effects, the specific loss of these antigenic sites in the
adsorbed Mb, coupled with the retention of others, indi-
cates the nonrandom nature of the adsorbed Mb molecules.
The Mb molecules exhibit a preferred mode of adsorption,
either in terms of their orientation or their conformation,
because each antibody would be expected to bind to
randomly adsorbed Mb with the same affinity relative to
that for Mb in solution.
As random adsorption and native conformation of
adsorbed protein antigen are important assumptions in
many solid-phase immunoassay methods, these results
have important implications for the interpretation of such
studies. Conformational changes of adsorbed proteins and
nonrandom adsorption may also influence cell/substrate
interactions (1-3), and play a role in chromatographic
separations of proteins and in thrombosis and other intra-
vascular protein/surface interactions (4, 5). The use of
conformation-specific monoclonal antibodies provides a
sensitive tool to reveal the effects of surface adsorption on
protein antigen.
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